Cunderlíková, B. Issues to be considered when studying cancer in vitro. Crit. Rev. Oncol. Hematol. 85, 95–111 (2013).
Kahn, J. et al. Preclinical models in radiation oncology. Radiat. Oncol. 7, 223–227 (2012).
Giard, D.J. et al. In
vitro cultivation of human tumors: establishment of cell lines derived from a series of solid
tumors. J. Natl. Cancer Inst. 51, 1417–1423 (1973).
Herrmann, D. et al. Three-dimensional cancer models mimic cell-matrix interactions in the tumour microenvironment. Carcinogenesis 35, 1671–1679 (2014).
Schmidt, F. & Efferth, T. Tumor heterogeneity, single-cell sequencing, and drug resistance. Pharmaceuticals (Basel) 9, 33 (2016).
Chapman, S. et al. Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J. Clin. Invest. 120, 2619–2626 (2010).
Liu, X. et al. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am. J. Pathol. 180, 599–607 (2012).
Suprynowicz, F.A. et al. Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells. Proc. Natl. Acad. Sci. USA 109, 20035–20040 (2012).
Watanabe, K. et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25, 681–686 (2007).
Terunuma, A. et al. Efficient procurement of epithelial stem cells from human tissue specimens using a Rho-associated protein kinase inhibitor Y-27632. Tissue Eng. Part A 16, 1363–1368 (2010).
Rheinwald, J.G. & Green, H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6, 331–343 (1975).
Yue, J. et al. Cutaneous human papillomavirus type 38 E7 regulates actin cytoskeleton structure for increasing cell proliferation through CK2 and the eukaryotic elongation factor 1A. J. Virol. 85, 8477–8494 (2011).
Charette, S.T. & McCance, D.J. The E7 protein from human papillomavirus type 16 enhances keratinocyte migration in an Akt-dependent manner. Oncogene 26, 7386–7390 (2007).
Yuan, H. et al. Use of reprogrammed cells to identify therapy for respiratory papillomatosis. N. Engl. J. Med. 367, 1220–1227 (2012).
Prater, M.D. et al. Mammary stem cells have myoepithelial cell properties. Nat. Cell Biol. 16, 942–950 (2014).
Walters, B.J. et al. Pseudo-immortalization of postnatal cochlear progenitor cells yields a scalable cell line capable of transcriptionally regulating mature hair cell genes. Sci. Rep. 5, 17792 (2015).
Hata, A.N. et al. Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition. Nat. Med. 22, 262–269 (2016).
Garraway, L.A Lander E.S. Lessons from the cancer genome. Cell 153, 17–37 (2013).
Brown, D.D. et al. Developing in vitro models of human ductal carcinoma in situ from primary tissue explants. Breast Cancer Res. Treat. 153, 311–21 (2015).
Boehm, J.S. & Golub, T.R. An ecosystem of cancer cell line factories to support a cancer dependency map. Nat. Rev. Genet. 16, 373–4 (2015).
Chu, H.W. et al. CRISPR-Cas9-mediated gene knockout in primary human airway epithelial cells reveals a proinflammatory role for MUC18. Gene Ther. 22, 822–9 (2015).
Friedman, A.A. et al. Precision medicine for cancer with next-generation functional diagnostics. Nat. Rev. Cancer 15, 747–56 (2015).
Crystal, A.S. et al. Patient-derived models of acquired resistance can identify effective drug combinations for cancer. Science 346, 1480–1486 (2014).
Beglyarova, N. et al. Screening of conditionally reprogrammed patient-derived carcinoma cells identifies ERCC3-MYC interactions as a target in pancreatic cancer. Clin. Cancer Res. 22, 6153–6163 (2016).
Saeed, K. et al. Comprehensive drug testing of patient-derived conditionally reprogrammed cells from castration-resistant prostate cancer. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2016.04.019 (2016).
Veit, G. et al. Ribosomal stalk protein silencing partially corrects the ΔF508-CFTR functional expression defect. PLoS Biol. 14, e1002462 (2016).
Butler, C.R. et al. Rapid expansion of human epithelial stem cells suitable for airway tissue engineering. Am. J. Respir. Crit. Care Med. 194, 156–168 (2016).
Thangapazham, R.L. et al. Dissociated human dermal papilla cells induce hair follicle neogenesis in grafted dermal-epidermal composites. J. Invest. Dermatol. 134, 538–540 (2014).
Thangapazham, R.L. et al. A model system to analyse the ability of human keratinocytes to form hair follicles. Exp. Dermatol. 23, 443–446 (2014).
Jin, K. et al. Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review. Clin. Transl. Oncol. 12, 473–480 (2010).
Fulcher, M.L. & Randell, S.H. Human nasal and tracheo-bronchial respiratory cell culture. Methods Mol. Biol. 945, 109–121 (2013).
Ali, S.H. & DeCaprio, J.A. Cellular transformation by SV40 large T antigen: interaction with host proteins. Semin. Cancer Biol. 11, 15–23 (2001).
Shay, J.W. & Wright, W.E. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26, 867–874 (2005).
Wilding, J.L. & Bodmer, W.F. Cancer cell lines for drug discovery and development. Cancer Res. 74, 2377–2384 (2014).
Wright, W.E. & Shay, J.W. The two-stage mechanism controlling cellular senescence and immortalization. Exp. Gerontol. 27, 383–389 (1992).
Curry, E.L. et al. Using induced pluripotent stem cells as a tool for modelling carcinogenesis. World J. Stem Cells 7, 461–469 (2015).
Seki, T. & Fukuda, K. Methods of induced pluripotent stem cells for clinical application. World J. Stem Cells 7, 116–125 (2015).
de Miguel-Beriain, I. The ethics of stem cells revisited. Adv. Drug Deliv. Rev. 82–83, 176–180 (2015).
Chen, G. et al. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 8, 424–429 (2011).
Williams, S.A. et al. Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century. Lab. Invest. 93, 970–982 (2013).
Tentler, J.J. et al. Patient-derived tumour xenografts as models for oncology drug development. Nat. Rev. Clin. Oncol. 9, 338–350 (2012).
Boone, J.D. et al. Ovarian and cervical cancer patient derived xenografts: the past, present, and future. Gynecol. Oncol. 138, 486–491 (2015).
Bernardo, C. et al. Patient-derived bladder cancer xenografts: a systematic review. Transl. Res. 166, 324–331 (2015).
Boj, S.F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324–338 (2015).
van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933–945 (2015).
Sachs, N. & Clevers, H. Organoid cultures for the analysis of cancer phenotypes. Curr. Opin. Genet. Dev. 24, 68–73 (2014).
Li, X. et al. Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture. Nat. Med. 20, 769–777 (2014).
Nadauld, L.D. et al. Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer. Genome Biol. 15, 428 (2014).
Drost, J. et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 52, 43–47 (2015).
Palechor-Ceron, N. et al. Radiation induces diffusible feeder cell factor(s) that cooperate with ROCK inhibitor to conditionally reprogram and immortalize epithelial cells. Am. J. Pathol. 183, 1862–1870 (2013).
McAuliffe, P.F. et al. Cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomes. PLoS One 10, e0136851.
Varma, S. & Gottesman, M.M. The clinical relevance of cancer cell lines. J. Natl. Cancer Inst. 105, 452–458 (2013).